Drug Topics
DECEMBER 29, 2022
The American Diabetes Association has updated their Standards of Care, which includes new hypertension guidelines, medication guidance, and emphasis on weight loss.
Pharmacy Times
DECEMBER 29, 2022
From newsworthy moments to groundbreaking research, these were the most-read articles on Pharmacy Times in 2022.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
DECEMBER 29, 2022
Take a look back at our most popular dermatology coverage for 2022.
Fierce Pharma
DECEMBER 29, 2022
Biogen, FDA's inappropriate Aduhelm coordination detailed in blistering congressional report. aarmstrong. Thu, 12/29/2022 - 14:42.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Store News
DECEMBER 29, 2022
The second panel at Drug Store New’s 24th annual Industry Issues Summit explored how retailers and pharmacy technology companies are responding to customers’ and patients’ needs.
STAT
DECEMBER 29, 2022
The very term “chronic disease” might imply that little changes — or improves — over time. But there is a lot percolating on the chronic disease front, from the mysterious (long Covid) to well-known problems. For the millions of people in the United States who have one or more chronic conditions, a small scientific stir can lead to a huge impact.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
DECEMBER 29, 2022
The downfall of Aduhelm, the first new treatment for Alzheimer’s disease in two decades, is largely the story of a drug company choosing to maximize its potential profits at the expense of patients and taxpayers, according to a congressional investigation that cites thousands of pages of internal Biogen documents. More than a year before Aduhelm’s June 2021 approval, Biogen surveyed insurance companies and doctors about how much the Alzheimer’s treatment should cost.
Board Vitals - Pharmacist
DECEMBER 29, 2022
We dug through Instagram and asked for nominations to come up with a list of Instagram doctors you may not know about but absolutely must follow immediately. Instagram is a great place to catch up on the latest trends, find motivation, and learn about people and things you may not have known before. Physician accounts on Instagram are a great way to get some interesting insights and knowledge.
STAT
DECEMBER 29, 2022
Congressional investigators sorted through more than 500,000 pages of documents from the Food and Drug Administration and Biogen to chronicle how a controversial Alzheimer’s disease drug was approved, and how it went from what was supposed to be the biggest drug launch in history to a financial catastrophe. The resulting report is filled with fresh details about how one of the most storied biotech companies plotted with the federal agency that is supposed to regulate it, and how Biogen de
DiversifyRx
DECEMBER 29, 2022
Explore our Top 2022 recommendations for Optimizing Your PBM Revenue and Stabilizing Your Pharmacy Profits. Last week we shared our Top 2022 Pharmacy Blog Post for Non-PBM Revenue , which covers our second Pharmacy Profit Pillar Non-PBM Revenue. This week we will recap the most popular blogs from 2022 that focus on PBM Optimization , our third Pharmacy Profit Pillar.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
DECEMBER 29, 2022
Pfizer said Thursday that its experimental gene therapy for hemophilia B significantly reduced the number of bleeds patients experienced over a year. Data from the 45-patient trial could set the stage for a second gene therapy to be approved for patients with the rare and serious bleeding disorder in as many years. In November, UniQure won approval for Hemgenix, the first hemophilia B gene therapy.
Drug Store News
DECEMBER 29, 2022
Drug Store News recently spoke with Dawn Garvey, chief financial officer, about the company’s anniversary, its future and where the greeting cards category is headed.
STAT
DECEMBER 29, 2022
WASHINGTON — The Food and Drug Administration’s review and approval of a controversial Alzheimer’s drug was “rife with irregularities,” including dozens of undisclosed calls and emails with Biogen and an “inappropriate” level of coordination between the drugmaker and regulators, a congressional investigation concluded.
pharmaphorum
DECEMBER 29, 2022
A new Data Protection and Digital Information Bill is currently being considered by UK ministers. The Bill has been created to update and simplify the UK’s data protection framework with a view to reducing burdens on organisations, providing them with greater flexibility on how to comply with certain aspects of the data protection legislation and improving the clarity of the framework.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Drug Store News
DECEMBER 29, 2022
Crossmark’s Kristen Abreu discusses how the company invests in technology and tools to help retail brands understand shopper trends.
STAT
DECEMBER 29, 2022
Dear Reader, From STAT’s first investigations in June 2021 revealing why the FDA gave the go-ahead for a marginally effective Alzheimer’s drug manufactured by Biogen, we have relentlessly stayed on the story. We’ve reported on the disastrous financial and leadership consequences for a one-time biopharma behemoth, as well as the dashed hopes of millions of people with dementia who had heard of a new drug called Aduhelm.
Pharmacy Times
DECEMBER 29, 2022
Both benefits and concerns exist, but implementing policies and regulations promotes employee productivity, guards safety.
The Guardian - Pharmaceutical Industry
DECEMBER 29, 2022
House of Representatives’ report details ‘corporate greed’ and ‘atypical review process’ preceding agency’s approval of Biogen’s drug US drug regulators failed to follow their own guidance and practices when they approved the controversial Alzheimer’s drug Aduhelm, a congressional report said on Thursday. The US food and drug administration’s (FDA) process of approval, it said, had been “rife with irregularities”, and the FDA’s interactions with maker Biogen had been “atypical”.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Fierce Pharma
DECEMBER 29, 2022
After FDA's Ukoniq pull, TG Therapeutics wins commercial mulligan with Briumvi to enter crowded MS arena. fkansteiner. Thu, 12/29/2022 - 09:30.
Drug Store News
DECEMBER 29, 2022
Catalina’s Shopper Intelligence data shows a sharp increase in OTC flu, RSV treatment unit sales as prices rise.
Fuld
DECEMBER 29, 2022
Social Media and Text Analytics. Leverage social media and NLP (natural language processing) analytics for applications in marketing and beyond. Marketing. Identifying key Influencers to maximize influence, creating customer social personas, social CRM, tracking and benchmarking competitor social media, and media performance analytics. Customer Voice.
BuzzRx
DECEMBER 29, 2022
Kidney stones and bladder stones are hard deposits of minerals and salts that form in the urinary tract. Other names for stones in the urinary tract include renal calculi, urolithiasis, and nephrolithiasis. Bladder stones & kidney stones develop in concentrated urine. When urine is concentrated, it causes the minerals in the urine to crystallize and form stones.
Fuld
DECEMBER 29, 2022
Competitive Intelligence Analytics. Track and stay ahead of your competition through automated KPI and news feeds visualized in dynamic dashboards. Company-specific data. Tracking financials, press releases, product launches, key developments, news mentions, employment trends, engagement trends from social media, and more. Industry-specific metrics.
BuzzRx
DECEMBER 29, 2022
If you’ve noticed blood in your urine , you’re probably worried about what it means. The medical term for this is hematuria. Blood in the urine can be from something harmless, like eating certain foods, but blood in your urine can also indicate something more far more serious, such as a urinary tract infection , kidney stones , kidney cancer, or bladder cancer.
The Checkup by Singlecare
DECEMBER 29, 2022
Is Nuedexta covered by insurance? | How much does Nuedexta cost without insurance? | How to get Nuedexta without insurance. Nuedexta is a brand-name prescription drug that treats pseudobulbar affect ( PBA). Consisting of involuntary and unexpected outbursts of crying or laughing unrelated to mood, PBA is a relatively common symptom of underlying neurological conditions, such as stroke, brain injury , dementia, multiple sclerosis , Parkinson’s disease, or amyotrophic lateral sclerosis (ALS).
PQA
DECEMBER 29, 2022
PQA has published nearly 90 blogs this year, providing insights and updates on our work to improve medication use quality. As we close out 2022, here’s a look back at the top five blogs of the year. 5. PQA’s Plan to Improve Oral Anticancer Medication Use Quality (October 10) PQA is launching a national initiative to prioritize research and measurement strategies to improve the quality of care for individuals using oral anticancer medications (OAM).
The Checkup by Singlecare
DECEMBER 29, 2022
Compare omeprazole alternatives | Nexium | Prevacid | Pepcid | Carafate | Tums | Natural alternatives | How to switch meds. The brand-name heartburn medication Prilosec, known generically as omeprazole , has such widespread usage that it is a household name. This is partly related to the prevalence of gastroesophageal reflux disease (GERD) , but in addition, the drug’s impressive effectiveness has earned it this status.
Drug Store News
DECEMBER 29, 2022
The new collaboration leverages MyEyeDr.’s 850+ offices to refer patients into ophthalmology clinical trials.
The Checkup by Singlecare
DECEMBER 29, 2022
Is Fycompa covered by insurance? | How much does Fycompa cost without insurance? | How to get Fycompa without insurance. Fycompa is a brand-name prescription drug used alone or with other anticonvulsants to prevent partial-onset seizures and tonic-clonic seizures (convulsive seizures) in people with epilepsy. Its active ingredient, perampanel, is an AMPA-receptor antagonist that slows down the brain by blocking nerve signals.
Drug Store News
DECEMBER 29, 2022
The company successfully launched 26 new generic products in 2022.
The Checkup by Singlecare
DECEMBER 29, 2022
Overview: What does multiple sclerosis (MS) feel like? Multiple sclerosis is an autoimmune disease that affects nerves in the brain and spinal cord. The immune system attacks the myelin sheath, the protective layer around nerves. This interrupts the nerve signals to and from the brain. Because nerve damage can occur anywhere in the central nervous system, people have widely varying experiences and symptoms from numbness and vision changes to muscle twitching and paralysis. .
PharmExec
DECEMBER 29, 2022
Personalized medicine continued its growth over the past year and became one of the most talked about topics in the life sciences industry.
pharmaphorum
DECEMBER 29, 2022
As we close out the year, pharmaphorum’s editorial team sat down together for a roundtable discussion of some of the biggest trends they tracked this year in the world of pharma. . Join editor-in-chief Jonah Comstock, founder Paul Tunnah, Deep Dive editor Eloise McLennan, and web editor Nicole Raleigh for a wide-ranging discussion touching on clinical trials, patient centricity, COVID-19’s impact on digital health, precision medicine, and artificial intelligence and machine learning. .
Expert insights. Personalized for you.
247 
Let's personalize your content